Stockport Exploration Inc. Announces Definitive Agreement for Amalgamation with Sona Nanotech Ltd

You may also like

Sona Presents Additional Preclinical Data Demonstrating Repeated Ability Of Its Cancer Therapy To Inhibit Tumor Growth In Colorectal Cancer Model

Sona Nanotech to Present Targeted Hyperthermia Therapy at the 19th International Canadian Melanoma Conference

Sona Nanotech’s THT Cancer Therapy Preclinical Efficacy Studies Published In Peer-reviewed Scientific Journal

Sona Nanotech’s THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study